Skip to content

Home
technology
Unnecessary
Health Care
Necessary
Financials
Energy
Industrials
Basic Materials
Telecommunications
Utilities

Home » PFE » UBS Group Reiterates $45.00 Price Target for Pfizer (NYSE:PFE)

UBS Group Reiterates $45.00 Price Target for Pfizer (NYSE:PFE)

March 20, 2023 by legume

UBS Group Reiterates $45.00 Price Target for Pfizer (NYSE:PFE)

Categories Health Care Tags PFE, Pfizer, UBS

Wells Fargo Lowered Pfizer(NYSE:PFE) Price Target from $50.00 to $44.00

Tyson Foods (NYSE:TSN) will close two U.S. chicken plants involving nearly 1,700 employees

Leave a Comment Cancel reply

Comment

Name Email Website

Save my name, email, and website in this browser for the next time I comment.

Search

Recent Posts

Morningstar lowered NVIDIA (NASDAQ:NVDA) Price Target to $300
Telsey Advisory lowered VF (NYSE:VFC) price target from $36 to $27
Wedbush Raises VF (NYSE:VFC) Price Target to $21 From $19
Citigroup Trims Price Target on VF (NYSE:VFC) to $20 From $22
Barclays lowered VF (NYSE:VFC) price target from $26 to $20

Recent Comments

No comments to show.

© 2023 DD STOCK • Built with GeneratePress